Journalartikel

Neurotrophic Tyrosine Kinase Receptor B/Neurotrophin 4 Signaling Axis Is Perturbed in Clinical and Experimental Pulmonary Fibrosis


AutorenlisteAvcuoglu, Sibel; Wygrecka, Malgorzata; Marsh, Leigh M.; Guenther, Andreas; Seeger, Werner; Weissmann, Norbert; Fink, Ludger; Morty, Rory E.; Kwapiszewska, Grazyna

Jahr der Veröffentlichung2011

Seiten768-780

ZeitschriftAmerican Journal of Respiratory Cell and Molecular Biology

Bandnummer45

Heftnummer4

ISSN1044-1549

DOI Linkhttps://doi.org/10.1165/rcmb.2010-0195OC

VerlagAmerican Thoracic Society


Abstract
The neurotrophins (NTs) are emerging as exciting new participants in normal lung physiology, as well as in several pathological processes in diseased lungs. In this study, the increased expression of NT4/5 and of its cognate receptor, the neurotrophic tyrosine kinase receptor Type 2 (TrkB), was observed in human lungs explanted from patients with idiopathic pulmonary fibrosis (IPF), and in lungs from mice with bleomycin-induced pulmonary fibrosis. The expression of NT4/5 and TrkB localized to hyperplastic alveolar Type II cells (ATII) and fibroblastic foci in affected lungs. Increased concentrations of NT4/5 and TrkB were evident in ATII isolated from the lungs of bleomycin-treated mice. Primary ATII were shown to secrete NT4/5 into the cell culture medium. The profibrotic cytokine transforming growth factor-beta 1, stimulated TrkB, but not NT4/5 gene expression, suggesting that perturbed profibrotic growth factor signaling in affected lungs may drive the expression of TrkB. NT4/5 enhanced the proliferation of ATII through a TrkB/extracellular-regulated kinase/protein kinase B pathway, and could also drive the proliferation of primary human and murine lung fibroblasts, through TrkB-dependent and protein kinase B-dependent pathways. Taken together, these data suggest that a dysregulated TrkB/NT4/5 axis may contribute to several of the pathological lesions associated with pulmonary fibrosis, including ATII hyperplasia and the proliferation of fibroblasts, and we would add IPF to the list of disorders, such as pain and cancer, for which therapeutic targeting of the TrkB/neurotrophin axis has been proposed for further investigation.



Zitierstile

Harvard-ZitierstilAvcuoglu, S., Wygrecka, M., Marsh, L., Guenther, A., Seeger, W., Weissmann, N., et al. (2011) Neurotrophic Tyrosine Kinase Receptor B/Neurotrophin 4 Signaling Axis Is Perturbed in Clinical and Experimental Pulmonary Fibrosis, American Journal of Respiratory Cell and Molecular Biology, 45(4), pp. 768-780. https://doi.org/10.1165/rcmb.2010-0195OC

APA-ZitierstilAvcuoglu, S., Wygrecka, M., Marsh, L., Guenther, A., Seeger, W., Weissmann, N., Fink, L., Morty, R., & Kwapiszewska, G. (2011). Neurotrophic Tyrosine Kinase Receptor B/Neurotrophin 4 Signaling Axis Is Perturbed in Clinical and Experimental Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 45(4), 768-780. https://doi.org/10.1165/rcmb.2010-0195OC



Schlagwörter


alveolar Type IIFIBROBLASTGROWTH-FACTORhuman lungIdiopathic pulmonary fibrosisNeurotrophinPROTEIN EXPRESSIONTRK RECEPTORS


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:40